Insider Trading June 5, 2026 05:01 PM

SurgePays Director David May Accumulates $21,151 in Shares Amid Stock Decline

Insider buying occurs as the company navigates a challenging financial quarter and strategic technology initiatives.

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn
SURG

David May, a director at SurgePays, Inc. (NASDAQ:SURG), recently executed a series of share purchases totaling $21,151. The transactions, detailed in a Form 4 filing with the Securities and Exchange Commission, took place over three consecutive days in early June. May acquired 40,250 shares at a fixed price of $0.5255 per share, following a limit order placed on June 3, 2026. This insider activity comes as SURG trades near its 52-week low of $0.46, reflecting a significant 81% decline over the past year. Analysts suggest the stock may be undervalued at current levels, though the company recently reported a first-quarter 2026 earnings miss and a substantial revenue shortfall.

SurgePays Director David May Accumulates $21,151 in Shares Amid Stock Decline
SURG
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Director David May purchased 40,250 shares of SURG at $0.5255 per share, totaling $21,151, over three days in early June. This insider buying activity occurs as the stock trades near its 52-week low of $0.46, down 81% over the past year. The purchase was executed via a limit order placed on June 3, 2026.
  • SurgePays reported a significant miss in its first-quarter 2026 financial results, with an EPS of -$0.51 versus a forecasted $0.01, and revenue of $15.98 million compared to the anticipated $31.7 million. The company has also engaged BrandRap to develop a real-time AI decisioning engine for its ProgramBenefits.com platform, with Phase 1 production expected by July 2026.
  • Following the recent acquisitions, Mr. May directly owns 156,626 shares of SurgePays common stock. The reported direct ownership figure does not include other shares deemed beneficially owned by Mr. May, which include 41,750 shares held by XIV LLC, 15,000 shares issuable from previous restricted share awards, and 12,295 shares held in the name of Mr. May’s spouse.

David May, serving as a director at SurgePays, Inc. (NASDAQ:SURG), has completed a series of share purchases totaling $21,151. The transactions, documented in a Form 4 filing submitted to the Securities and Exchange Commission, were executed over a three-day period in early June. May acquired a total of 40,250 shares at a price of $0.5255 per share. These purchases were made pursuant to a limit order for 40,250 shares at that specific price, which was entered on June 3, 2026.

The transactions were executed on the following dates:

  • June 3, 2026: 5,413 shares were purchased.
  • June 4, 2026: 121 shares were purchased.
  • June 5, 2026: 34,716 shares were purchased.

The purchases come as SURG trades near its 52-week low of $0.46, with the stock down 81% over the past year. According to InvestingPro analysis, the stock appears undervalued at current levels, with 16 additional ProTips available to subscribers offering deeper insights into the company’s financial position.

Following these acquisitions, Mr. May directly owns 156,626 shares of SurgePays common stock. The reported direct ownership figure does not include other shares deemed beneficially owned by Mr. May, which include 41,750 shares held by XIV LLC, 15,000 shares issuable from previous restricted share awards, and 12,295 shares held in the name of Mr. May’s spouse.

In other recent news, SurgePays Inc. reported its first-quarter 2026 earnings, which fell short of expectations. The company announced an earnings per share (EPS) of -$0.51, significantly missing the forecasted $0.01. Additionally, SurgePays reported revenue of $15.98 million, which was well below the anticipated $31.7 million, resulting in a surprise of -49.59%. In another development, SurgePays has engaged BrandRap, a consultancy firm based in Irvine, California, to develop a real-time AI decisioning engine for its ProgramBenefits.com platform. This engine aims to score eligibility and predict conversion probability across various verticals, with Phase 1 production expected by July 2026. These updates reflect the latest developments in the company’s strategic and financial activities.

Risks

  • SurgePays reported a significant miss in its first-quarter 2026 financial results, with an EPS of -$0.51 versus a forecasted $0.01, and revenue of $15.98 million compared to the anticipated $31.7 million. This financial shortfall may impact investor confidence and the company's cash flow durability.
  • The stock has declined 81% over the past year and is trading near its 52-week low of $0.46. This prolonged decline may indicate broader market challenges or sector-specific headwinds affecting the company's valuation and liquidity.
  • SurgePays has engaged BrandRap to develop a real-time AI decisioning engine for its ProgramBenefits.com platform, with Phase 1 production expected by July 2026. The successful implementation of this technology is critical for the company's strategic initiatives, but any delays or failures could impact its competitive position and future revenue streams.

More from Insider Trading

Nano Nuclear Energy Director Disposes of All Shares Following RSU Vesting Jun 5, 2026 Beta Bionics Director Jones Christy Executes Pre-Arranged Stock Sale Jun 5, 2026 MiNK Therapeutics Director Disposes of $19,141 in Common Stock Jun 5, 2026 Beta Bionics Executive Sells Shares Under Pre-Arranged Plan Jun 5, 2026 Outset Medical CFO Executes Tax-Related Stock Sale Amid Strategic Focus Jun 5, 2026